X

Please provide your details and we'll get in touch within 24 hours

  • Check Speaker Availability

  • This field is for validation purposes and should be left unchanged.
Emmanuelle Charpentier Speaker

Emmanuelle Charpentier

Berlin, Germany

Director, Max Planck Institute for Infection Biology

Co-founder of CRISPR Therapeutics and ERS Genomics

Honorary Professor, Humboldt University

Emmanuelle Charpentier Speaker Profile:

Emmanuelle Charpentier is a French microbiologist, geneticist and biochemist. She is a Director at the Max Planck Institute for Infection Biology in Berlin, Honorary Professor at Humboldt University, and recipient of an Alexander von Humboldt Professorship. Prior to her current appointments, she has worked at several other institutions in Germany, Sweden, Austria, the US and France.

Prof. Charpentier’s research on a bacterial immune system laid the foundation for the ground-breaking CRISPR-Cas9 genome engineering technology. She has received numerous prestigious awards and distinctions, and is an elected member of several academies of sciences. She is co-founder of CRISPR Therapeutics and ERS Genomics.

Charpentier studied biochemistry, microbiology and genetics at the University Pierre and Marie Curie, Paris, France and obtained her PhD in Microbiology for her research performed at the Pasteur Institute. She then continued her work in the United States, at The Rockefeller University, New York University Langone Medical Center and the Skirball Institute of Biomolecular Medicine (all in New York, NY) and at St Jude Children’s Research Hospital (in Memphis, TN). E. Charpentier returned to Europe to establish her own research group at the Max F. Perutz Laboratories of the University of Vienna in Austria where she habilitated in the field of Microbiology. She was then appointed Associate Professor at the Laboratory for Molecular Infection Medicine Sweden (MIMS, part of Nordic European Molecular Biology Laboratory (EMBL) Partnership for Molecular Medicine) at Umeå University in Sweden where she habilitated in the field of Medical Microbiology and is still active as a Visiting Professor. Between 2013 and 2015, E. Charpentier was Head of the Department of Regulation in Infection Biology at the Helmholtz Centre for Infection Research, Braunschweig, and Professor at the Medical School of Hannover in Germany. In 2013, she was awarded an Alexander von Humboldt Professorship, which she has held since 2014. In 2015, E. Charpentier was appointed Scientific Member of the Max Planck Society in Germany and Director at the Max Planck Institute for Infection Biology in Berlin, Germany.

Charpentier is recognized as a world-leading expert in regulatory mechanisms underlying processes of infection and immunity in bacterial pathogens. Her work has led to a number of seminal discoveries and insights into pathways governing antibiotic resistance and virulence of bacterial pathogens. With her recent groundbreaking findings in the field of RNA-mediated regulation based on the CRISPR-Cas9 system, Charpentier has laid the foundation for the development of a novel, highly versatile and specific genome editing technology that is revolutionizing life sciences research and could open up whole new opportunities in biomedical gene therapies. The resulting field of research is now developing at dazzling speed, with exciting new aspects emerging almost weekly. For this research, E. Charpentier has been awarded a number of prestigious honors.

For availability and speaker fees, please contact Emmanuelle Charpentier’s speaking agent at Chartwell here, or call +1 972 385 1021 for U.S. inquiries or +44 207 293 0864 for international inquiries.

get in touch

We’re here to help.

If you can’t find the right speaker you need, or would like speaker ideas tailored to your event,

talk to us on the details below.

For UK, Europe and general enquiries, please contact

Rob Higgins

+44 207 293 0864

For US enquiries,

please contact

Ellis Trevor

+1 516 6581608

For Middle East, Asia & international enquiries

please contact

Raleigh Addington

+852 5819 2227